🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, asserting the corporations hid potential risks that the medication created to pediatric cognitive development.

This legal action follows a month after President Donald Trump advocated an unverified association between using acetaminophen - referred to as paracetamol - throughout gestation and autism in young ones.

The attorney general is suing the pharmaceutical giant, which formerly manufactured the medication, the exclusive pain medication suggested for pregnant women, and the current manufacturer, which presently makes it.

In a declaration, he claimed they "misled consumers by profiting off of pain and marketing drugs ignoring the dangers."

The company says there is lacking scientific proof connecting acetaminophen to autism.

"These companies misled for generations, knowingly endangering countless individuals to boost earnings," the attorney general, from the Republican party, declared.

The company commented that it was "very worried by the perpetuation of misinformation on the safety of acetaminophen and the likely effects that could have on the well-being of American women and children."

On its official site, Kenvue also mentioned it had "consistently assessed the relevant science and there is lacking reliable evidence that shows a verified association between using paracetamol and autism."

Organizations representing doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the key substance in Tylenol - is among limited choices for pregnant women to manage pain and fever, which can create serious health risks if left untreated.

"In multiple decades of studies on the utilization of paracetamol in gestation, not a single reputable study has definitively established that the use of acetaminophen in any trimester of pregnancy results in neurodevelopmental disorders in young ones," the group commented.

The court filing mentions recent announcements from the former administration in claiming the drug is potentially dangerous.

In recent weeks, the former president caused concern from medical authorities when he advised pregnant women to "fight like hell" not to use Tylenol when ill.

Federal regulators then issued a notice that physicians should think about restricting the usage of Tylenol, while also mentioning that "a causal relationship" between the drug and autism in young ones has not been proven.

Health Secretary Kennedy, who manages the FDA, had pledged in spring to conduct "extensive scientific investigation" that would identify the source of autism in a limited time.

But experts warned that finding a single cause of autism spectrum disorder - thought by researchers to be the outcome of a complex mix of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a form of lifelong neurodivergence and disability that affects how people encounter and interact with the environment, and is recognized using physician assessments.

In his lawsuit, Paxton - a Trump ally who is running for federal office - asserts Kenvue and J&J "deliberately disregarded and tried to quiet the research" around acetaminophen and autism spectrum disorder.

The case seeks to make the firms "remove any promotional materials" that states acetaminophen is safe for expectant mothers.

The court case parallels the concerns of a collection of guardians of young ones with autism and ADHD who took legal action against the producers of acetaminophen in 2022.

Judicial authorities threw out the case, declaring studies from the plaintiffs' authorities was lacking definitive proof.